Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer

Источник: Nasdaq GlobeNewswire / 24 май 2023 16:05:00   America/New_York